Fibronectin gene polymorphisms are associated with the development of B-cell lymphoma in type II mixed cryoglobulinemia

Annals of the Rheumatic Diseases

Volumn 67, Issue 1, 2008, Pages 80-83

  Fabris, M ^a   Quartuccio, L ^a   Salvin, S ^a   Pozzato, G ^b   De Re, V ^c   Mazzaro, C ^d   Ferri, C ^e   Baldini, C ^f   De Vita, S ^a,g  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY OF TRIESTE   (Italy)

^c CENTRO DI RIFERIMENTO ONCOLOGICO   (Italy)

^d S MARIA DEGLI ANGELI HOSPITAL   (Italy)

^e UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^f UNIVERSITY OF PISA   (Italy)

^g UNIVERSITY OF UDINE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CRYOGLOBULIN; FIBRONECTIN; RESTRICTION ENDONUCLEASE; RHEUMATOID FACTOR;

ALLELE; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; BLOOD DONOR; CANCER GROWTH; CELL PROLIFERATION; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CRYOGLOBULINEMIA; DISEASE COURSE; DNA POLYMORPHISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEPATITIS C VIRUS; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK; SAMPLE; SYSTEMIC VASCULITIS; TYPE II MIXED CRYOGLOBULINEMIA; VIRUS INFECTION;

CASE-CONTROL STUDIES; CRYOGLOBULINEMIA; FIBRONECTINS; GENE FREQUENCY; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, NON-HODGKIN; POLYMORPHISM, GENETIC; RISK ASSESSMENT; STATISTICS, NONPARAMETRIC;

EID: 37749040245     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2006.067637     Document Type: Article

References (22)

1. Meltzer M, Franklin EC. Cryoglobulinemia, a study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability. Am J Med 1966;40:828-36.
2. Ferri C, Mascia MT. Cryoglobulinemia vasculitis. Curr Opin Rheumatol 2006;18:54-63.
3. De Vita S, De Re V, Gasparotto D, Ballare M, Pivetta B, Ferraccioli G, et al. Oligoclonal non-neoplastic B cell expansion is the key feature of type II mixed cryoglobulinemia. Arthritis Rheum 2000;43:94-102.
4. Ferri C, Monti M, La Civita L, Longombardo G, Greco F, Pasero G, et al. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood 1993;82:3701-4.
5. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992;327:1490- 5.
6. De Re V, De Vita S, Marzotto A, Rupolo M, Gloghinim A, Pivetta B, et al. Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia. Blood 2000;96:3578-84.
7. De Re V, Sansonno D, Simula MP, Caggiari L, Gasparotto D, Fabris M, et al. HCV-NS3 and IgG-Fc crossreactive IgM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations. Leukemia 2006;20:1145-54.
8. Hynes RH, Yamada KM. Fibronectins: Multifunctional modular glycoproteins. J Cell Biol 1982;95:369-77.
9. Voss B, Allah S, Rauterberg J, Ullrich K, Gieselmann V, Von Figura K. Primary cultures of rat hepatocytes synthesize fibronectin. Biochem Biophys Res Commun 1979;90:1348-54.
10. Pearlstein E, Gold LI, Garcia-Pardo A. Fibronectin: a review on its structure and biological activity. Mol Cell Biochem 1980;29:103-28.
11. Furcht L. Structure and function of the adhesive glycoprotein fibronectin. Mol Cell Biol 1983;1:53-117.
12. Barilla ML, Carsons SE. Fibronectin fragments and their role in inflammatory arthritis. Semin Arthritis Rheum 2000;29:252-65.
13. Anderson V, Rucker M, Entwistle R, Schmid FR, Woos GW. Plasma fibronectin is a component of cryoglobulins from patients with connective tissue and other disorders. Ann Rheum Dis 1981;40:50-54.
14. Beaulieu AD, Valet JP, Strevey J. The influence of fibronectin on cryoprecipitates formation in rheumatoid arthritis and systemic lupus erythematosus. Arthritis Rheum 1981;24:1383-8.
15. Srevey J, Beaulieu AO, Menard C, Valet JP, Latulippe L, Hebert J. The role of fibronectin in the cryprecipitation of monoclonal cryoglobulins. Clin Exp Immunol 1984;55:340-6.
16. Levo V. Presence of fibronectin in cold precipitates of patients with cryoglobulinemia. Int Arch Allergy Appl Immunol 1982;68:178- 85.
17. Fornasieri A, Armelloni S, Bernasconi P, Lin M, Pinerolo de Septis C, Sinico RA, et al. High binding of immunoglobulin Mk Rheumatoid factor from type II cryoglobulins to cellular fibronectin: a mechanism for induction of in situ immune complex glomerulonephritis? Am J Kidney Diseases 1996;27:476-83.
18. Avila JJ, Lympany PA, Pantelidis P, Welsh KI, Black CM, du Bois RM. Fibronectin gene polymorphisms associated with fibrosing alveolitis in systemic sclerosis. Am J Respir Cell Mol Biol 1999;20:106-12.
19. Gardella R, Colombi R, Barlati S. Human fibronectin gene (FN1) RFLPs: mapping and linkage disequilibrium analysis. Human Genet 1993;92:639-41.
20. Invernizzi F, Pietrogrande M, Sagramoso B. Classification of the cryoglobulinemic syndrome. Clin Exp Rheumatol 1995;S13:123-8.
21. Vitali C. Classification criteria for Sjögren's syndrome. Ann Rheum Dis 2003;62:94-5.
22. Astier AL, Xu R, Svoboda M, Hinds E, Munoz O, de Beaumont R, et al. Temporal gene expression profile of human precursor B leukemia cells induced by adhesion receptor: identification of pathways regulating B-cell survival. Blood 2003;101:1118-27.